A review of the key aspects of screening, diagnosis and treatment of patients with portopulmonary hypertension and the various pulmonary hemodynamic patterns encountered in patients with liver disease.Read More
A pulmonologist describes how using an esophageal balloon can provide a more precise diagnosis and hemodynamic classification of pulmonary hypertension.
A recent study shows how equitable COVID-19 outcomes and reduced disparities in care can be achieved.
The SMARRT program, developed through a T32 grant from the NIH, promotes an entire curriculum of scholarship, training and mentoring for participants.
Research from three pulmonologists is shining light on mechanotransduction and ECM signal processing in ways that could lead to new therapeutic options.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Due in part to a unique infrastructure model along with consistent communication at all levels, Cleveland Clinic was able to remain agile in its response to the COVID-19 pandemic.
Despite substantial prevalence, neurosarcoidosis has eluded effective disease monitoring. Three recent studies suggest that might be starting to change.
New findings from a large retrospective study illustrate how understanding a patient’s pre-existing immune profile might impact COVID-19 outcomes.
Data suggest that intranasal corticosteroid use could be protective against the most severe outcomes of COVID-19 and warrants further analysis in a randomized clinical trial.
Study finds link between alcohol use disorder and increased hospitalizations and healthcare costs in patients with asthma or COPD.
Wearable, step-counting technologies may provide a new way for physicians to remotely monitor disease severity in patients with pulmonary arterial hypertension.